Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Handbook of Clinical Neurology|July 18, 2008
Biological transgenic mouse models of Alzheimer's diseaseLeslie Crews, Edward Rockenstein, Eliezer Masliah
Annals of the New York Academy of Sciences|July 9, 2003
Transgenic models of alpha-synuclein pathology: past, present, and futureMakoto Hashimoto, Edward Rockenstein, Eliezer Masliah
Brain Structure & Function|January 22, 2010
APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesisLeslie Crews, Edward Rockenstein, Eliezer Masliah
Advanced Drug Delivery Reviews|September 18, 2007
Transgenic animal models of neurodegenerative diseases and their application to treatment developmentEdward Rockenstein, Leslie Crews, Eliezer Masliah
Neuromolecular Medicine|October 7, 2003
Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseasesMakoto Hashimoto, Edward Rockenstein, Leslie Crews, et al.
Journal of Neurochemistry|June 6, 2003
Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's diseaseMakoto Hashimoto, Takato Takenouchi, Edward Rockenstein, et al.
Neurobiology of Disease|July 9, 2017
Increased BACE1 activity inhibits peripheral nerve regeneration after injuryCarolyn Tallon, Edward Rockenstein, Eliezer Masliah, et al.
Expert Opinion on Biological Therapy|November 24, 2007
Novel strategies for Alzheimer's disease treatmentBrian Spencer, Edward Rockenstein, Leslie Crews, et al.
Glia|December 7, 2013
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyElvira Valera, Kiren Ubhi, Michael Mante, et al.
Journal of Neuroinflammation|May 14, 2015
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's diseaseElvira Valera, Michael Mante, Scott Anderson, et al.
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Handbook of Clinical Neurology|July 18, 2008
Biological transgenic mouse models of Alzheimer's diseaseLeslie Crews, Edward Rockenstein, Eliezer Masliah
Annals of the New York Academy of Sciences|July 9, 2003
Transgenic models of alpha-synuclein pathology: past, present, and futureMakoto Hashimoto, Edward Rockenstein, Eliezer Masliah
Brain Structure & Function|January 22, 2010
APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesisLeslie Crews, Edward Rockenstein, Eliezer Masliah
Advanced Drug Delivery Reviews|September 18, 2007
Transgenic animal models of neurodegenerative diseases and their application to treatment developmentEdward Rockenstein, Leslie Crews, Eliezer Masliah
Neuromolecular Medicine|October 7, 2003
Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseasesMakoto Hashimoto, Edward Rockenstein, Leslie Crews, et al.
Journal of Neurochemistry|June 6, 2003
Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's diseaseMakoto Hashimoto, Takato Takenouchi, Edward Rockenstein, et al.
Neurobiology of Disease|July 9, 2017
Increased BACE1 activity inhibits peripheral nerve regeneration after injuryCarolyn Tallon, Edward Rockenstein, Eliezer Masliah, et al.
Expert Opinion on Biological Therapy|November 24, 2007
Novel strategies for Alzheimer's disease treatmentBrian Spencer, Edward Rockenstein, Leslie Crews, et al.
Glia|December 7, 2013
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyElvira Valera, Kiren Ubhi, Michael Mante, et al.
Journal of Neuroinflammation|May 14, 2015
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson's diseaseElvira Valera, Michael Mante, Scott Anderson, et al.
Pageof 20